Related Experiment Videos
[Structure and distribution of RU 41740]
1Laboratoire de Physiologie, Faculté Necker-Enfants malades, Paris.
Presse Medicale (Paris, France : 1983)
|July 27, 1988
Summary
RU 41740, derived from Klebsiella pneumoniae, is a glycoprotein compound that effectively crosses the intestinal barrier. This immunomodulator rapidly enters the lymphatic system after oral administration, showing potential for therapeutic applications.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Context:
- Klebsiella pneumoniae is a gram-negative bacterium known for its potential pathogenicity.
- Immunomodulators are compounds that can alter the immune response.
- Understanding the absorption and distribution of novel compounds is crucial for drug development.
Purpose:
- To characterize the composition and active components of RU 41740.
- To investigate the absorption and distribution of RU 41740 in vivo.
- To assess the interaction of RU 41740 with the digestive tract epithelium.
Summary:
- RU 41740, extracted from Klebsiella pneumoniae, is primarily composed of carbohydrates and proteins, with active glycoprotein subunits P1 (95 kD) and F1 (350 kD).
- Animal studies using radiolabeled RU 41740 demonstrated that the compound is absorbed through the intestinal wall.
- Following oral administration, RU 41740 was preferentially distributed to the lymphatic system and detected in the digestive tract epithelium.
Impact:
- Provides insights into the pharmacokinetic properties of RU 41740, suggesting potential for oral bioavailability.
- Highlights the interaction of RU 41740 with the gastrointestinal tract, a key site for immune modulation.
- Establishes a foundation for further research into the therapeutic efficacy and mechanisms of action of RU 41740.